Background Overall survival in hepatocellular carcinoma patients treated with percutaneous
radiofrequency ablation is influenced by both recurrence and successive treatments. We …

Objectives: The objective of this study is to compare the therapeutic efficacy of
radiofrequency ablation (RFA) and hepatic resection (HR) for the treatment of hepatocellular …

Background Randomized trials suggest that radiofrequency ablation (RFA) may be more
effective than percutaneous ethanol injection (PEI) in the treatment of hepatocellular …

Background Radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) is ordinarily
indicated for those with three or fewer nodules, none of which exceeds 3 cm in diameter …

Objective: The purpose of this study was to evaluate the risk factors for local recurrence with
radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) measuring≤ 2 cm …

The aim of this study was to investigate the therapeutic efficacy of percutaneous
radiofrequency (RF) ablation versus microwave (MW) ablation for hepatocellular carcinoma …

AIM: To investigate whether an ablative margin (AM)> 1.0 cm might reduce chance of
recurrence for patients with hepatocellular carcinoma (HCC) tumors 3.1 to 5.0 cm in size …

Background Radiofrequency ablation (RFA) is a new, minimally invasive treatment for
hepatocellular carcinoma (HCC). However, there is little available information regarding …

Background. Hepatocellular carcinoma (HCC) has seen a dramatic rise in the USA over the
last 30 years. Unresectable disease is present in 80–90% of patients, for which …

BACKGROUND: Local recurrence rates after radiofrequency ablation (RFA) of
hepatocellular carcinoma (HCC) vary from 2% to 36% in the literature. Limited data were …